ArticleCancer medicine2023

Use of monoclonal antibody therapy in hematologic patients with mild-to-moderate COVID-19: A retrospective single-center experience.

Idoroenyi Amanam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.